NCT03466736View on ClinicalTrials.gov

Enriching Clinical Trials Requiring Amyloid Positivity With Practice Effects

CompletedOBSERVATIONAL
Enrollment

165

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

April 20, 2023

Study Completion Date

April 20, 2023

Conditions
Alzheimer DiseaseMild Cognitive Impairment
Interventions
DIAGNOSTIC_TEST

[18F]flutemetamol PET scan

Each subject will receive an amyloid PET scan with \[18F\]flutemetamol

Trial Locations (1)

84108

University of Utah, Salt Lake City

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

University of Utah

OTHER

NCT03466736 - Enriching Clinical Trials Requiring Amyloid Positivity With Practice Effects | Biotech Hunter | Biotech Hunter